Legis Daily

To amend title XXVII of the Public Health Service Act and title XVIII of the Social Security Act to prohibit group health plans, health insurance issuers, prescription drug plan sponsors, and Medicare Advantage organizations from limiting certain information on drug prices.

USA115th CongressHR-6733| House 
| Updated: 9/13/2018
Earl L. "Buddy" Carter

Earl L. "Buddy" Carter

Republican Representative

Georgia

Cosponsors (21)
Paul A. Gosar (Republican)Michael C. Burgess (Republican)Erik Paulsen (Republican)Marsha Blackburn (Republican)Greg Walden (Republican)Debbie Dingell (Democratic)Bruce Poliquin (Republican)J. French Hill (Republican)James B. Renacci (Republican)Kurt Schrader (Democratic)H. Morgan Griffith (Republican)Rodney Davis (Republican)Gene Green (Democratic)Kevin Cramer (Republican)Anna G. Eshoo (Democratic)Peter Welch (Democratic)Susan W. Brooks (Republican)Cathy McMorris Rodgers (Republican)Jaime Herrera Beutler (Republican)Lloyd Doggett (Democratic)Brian Babin (Republican)

Ways and Means Committee, Health Subcommittee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Know the Cost Act of 2018 This bill prohibits a health insurance plan or pharmacy benefits manager from restricting a pharmacy from informing an enrollee of any difference between the cost of a drug under the plan and the cost of the drug without health insurance coverage. (Such restrictions are commonly referred to as gag clauses.)
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Sep 7, 2018
Introduced in House
Sep 7, 2018
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sep 13, 2018
Referred to the Subcommittee on Health.
Sep 13, 2018
Committee Consideration and Mark-up Session Held.
Sep 13, 2018
Ordered to be Reported by Voice Vote.
  • September 7, 2018
    Introduced in House


  • September 7, 2018
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.


  • September 13, 2018
    Referred to the Subcommittee on Health.


  • September 13, 2018
    Committee Consideration and Mark-up Session Held.


  • September 13, 2018
    Ordered to be Reported by Voice Vote.

Health

Related Bills

  • HR 115-6144: To amend title XVIII of the Social Security Act to prohibit health plans and pharmacy benefit managers from restricting pharmacies from informing individuals regarding the prices for certain drugs and biologicals.
  • S 115-2553: Know the Lowest Price Act of 2018
  • HR 115-6143: To ensure that health insurance issuers and group health plans do not prohibit pharmacy providers from providing certain information to enrollees.
  • S 115-2554: Patient Right to Know Drug Prices Act
Government information and archivesHealth care costs and insuranceInflation and pricesMedicarePrescription drugs

To amend title XXVII of the Public Health Service Act and title XVIII of the Social Security Act to prohibit group health plans, health insurance issuers, prescription drug plan sponsors, and Medicare Advantage organizations from limiting certain information on drug prices.

USA115th CongressHR-6733| House 
| Updated: 9/13/2018
Know the Cost Act of 2018 This bill prohibits a health insurance plan or pharmacy benefits manager from restricting a pharmacy from informing an enrollee of any difference between the cost of a drug under the plan and the cost of the drug without health insurance coverage. (Such restrictions are commonly referred to as gag clauses.)
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Sep 7, 2018
Introduced in House
Sep 7, 2018
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sep 13, 2018
Referred to the Subcommittee on Health.
Sep 13, 2018
Committee Consideration and Mark-up Session Held.
Sep 13, 2018
Ordered to be Reported by Voice Vote.
  • September 7, 2018
    Introduced in House


  • September 7, 2018
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.


  • September 13, 2018
    Referred to the Subcommittee on Health.


  • September 13, 2018
    Committee Consideration and Mark-up Session Held.


  • September 13, 2018
    Ordered to be Reported by Voice Vote.
Earl L. "Buddy" Carter

Earl L. "Buddy" Carter

Republican Representative

Georgia

Cosponsors (21)
Paul A. Gosar (Republican)Michael C. Burgess (Republican)Erik Paulsen (Republican)Marsha Blackburn (Republican)Greg Walden (Republican)Debbie Dingell (Democratic)Bruce Poliquin (Republican)J. French Hill (Republican)James B. Renacci (Republican)Kurt Schrader (Democratic)H. Morgan Griffith (Republican)Rodney Davis (Republican)Gene Green (Democratic)Kevin Cramer (Republican)Anna G. Eshoo (Democratic)Peter Welch (Democratic)Susan W. Brooks (Republican)Cathy McMorris Rodgers (Republican)Jaime Herrera Beutler (Republican)Lloyd Doggett (Democratic)Brian Babin (Republican)

Ways and Means Committee, Health Subcommittee, Energy and Commerce Committee

Health

Related Bills

  • HR 115-6144: To amend title XVIII of the Social Security Act to prohibit health plans and pharmacy benefit managers from restricting pharmacies from informing individuals regarding the prices for certain drugs and biologicals.
  • S 115-2553: Know the Lowest Price Act of 2018
  • HR 115-6143: To ensure that health insurance issuers and group health plans do not prohibit pharmacy providers from providing certain information to enrollees.
  • S 115-2554: Patient Right to Know Drug Prices Act
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Government information and archivesHealth care costs and insuranceInflation and pricesMedicarePrescription drugs